Dr. Vijaya R. Bhatt
Claim this profileUniversity of Nebraska Medical Center
Studies Leukemia
Studies Myeloid Leukemia
7 reported clinical trials
15 drugs studied
Area of expertise
1Leukemia
CD22 positive
TP53 positive
RUNX1 positive
2Myeloid Leukemia
TP53 positive
RUNX1 positive
ASXL1 positive
Affiliated Hospitals
Clinical Trials Vijaya R. Bhatt is currently running
Inotuzumab Ozogamicin Post-Transplant
for Leukemia and Lymphoma
This study has two phases, Phase I and Phase II. The main goal of the Phase I portion of this research study is to see what doses post-transplant inotuzumab ozogamicin can safely be given to subjects without having too many side effects. The Phase II portion of this study is to see what side effects are seen with medication after transplant. Inotuzumab ozogamicin is a combination of an antibody and chemotherapy which has been shown to have significant activity against relapsed/refractory acute lymphocytic leukemia (ALL). Inotuzumab ozogamicin is considered experimental in this study.
Recruiting1 award Phase 1 & 2
CPX-351
for Acute Myeloid Leukemia
This phase II trial studies how well liposome-encapsulated daunorubicin-cytarabine (CPX-351) works in treating patients with secondary acute myeloid leukemia who are younger than 60 years old. Drugs used in chemotherapy, such as CPX-351, work in different ways to stop the growth of cancer cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading.
Recruiting1 award Phase 213 criteria
More about Vijaya R. Bhatt
Clinical Trial Related7 years of experience running clinical trials · Led 7 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Vijaya R. Bhatt has experience with
- Venetoclax
- Liposome-encapsulated Daunorubicin-Cytarabine
- Inotuzumab Ozogamicin
- ONC201
- Cytarabine
- Idarubicin
Breakdown of trials Vijaya R. Bhatt has run
Leukemia
Myeloid Leukemia
Acute Myeloid Leukemia
Myelodysplastic Syndrome
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Vijaya R. Bhatt specialize in?
Vijaya R. Bhatt focuses on Leukemia and Myeloid Leukemia. In particular, much of their work with Leukemia has involved CD22 positive patients, or patients who are TP53 positive.
Is Vijaya R. Bhatt currently recruiting for clinical trials?
Yes, Vijaya R. Bhatt is currently recruiting for 4 clinical trials in Omaha Nebraska. If you're interested in participating, you should apply.
Are there any treatments that Vijaya R. Bhatt has studied deeply?
Yes, Vijaya R. Bhatt has studied treatments such as Venetoclax, Liposome-encapsulated Daunorubicin-Cytarabine, Inotuzumab Ozogamicin.
What is the best way to schedule an appointment with Vijaya R. Bhatt?
Apply for one of the trials that Vijaya R. Bhatt is conducting.
What is the office address of Vijaya R. Bhatt?
The office of Vijaya R. Bhatt is located at: University of Nebraska Medical Center, Omaha, Nebraska 68198 United States. This is the address for their practice at the University of Nebraska Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.